These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6574685)

  • 21. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen.
    Lahti E; Vuopala S; Kauppila A; Blanco G; Ruokonen A; Laatikainen T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):410-4. PubMed ID: 7835781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Transdermal and oral hormone substitution with estrogens: a comparison].
    Schindler AE
    Zentralbl Gynakol; 1995; 117(10):504-7. PubMed ID: 7491831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum estradiol and follicle-stimulating hormone levels in Thai women post total abdominal hysterectomy and bilateral oophorectomy using oral 17 beta-estradiol.
    Bunyavejchevin S; Panthong C; Limpaphayom KK
    J Med Assoc Thai; 2002 Jan; 85(1):58-62. PubMed ID: 12075721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being.
    Flöter A; Nathorst-Böös J; Carlström K; von Schoultz B
    Climacteric; 2002 Dec; 5(4):357-65. PubMed ID: 12626215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women.
    Labrie F; Cusan L; Gomez JL; Côté I; Bérubé R; Bélanger P; Martel C; Labrie C
    Menopause; 2009; 16(1):30-6. PubMed ID: 18820592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The influence of estrogen therapy on triglycerides. Importance of the choice of substance and the route of administration (author's transl)].
    Loeper J; Loeper MJ; Ohlghiesser C; de Lignières B; Mauvais-Jarvis P
    Nouv Presse Med; 1977 Sep; 6(31):2747-50. PubMed ID: 593814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous oestrogen therapy opposed by lynestrenol or natural progesterone--effects on circulating oestrogens, FSH, sex hormone binding globulin and pregnancy zone protein.
    Holst J; Cajander S; Carlström K; Damber MG; von Schoultz B
    Maturitas; 1983 Jun; 5(1):1-8. PubMed ID: 6410156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 17 beta-estradiol for postmenopausal estrogen replacement therapy.
    Nichols KC; Schenkel L; Benson H
    Obstet Gynecol Surv; 1984 Apr; 39(4):230-45. PubMed ID: 6717863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endometrial response following percutaneous estrogen replacement therapy. A morphometric investigation.
    Cajander S; Holst J; Carlström K; Damber MG; von Schoultz B
    Acta Obstet Gynecol Scand; 1983; 62(2):97-101. PubMed ID: 6408885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of unbound 17 beta-oestradiol during oral and percutaneous postmenopausal replacement therapy.
    Nilsson B; Holst J; von Schoultz B
    Br J Obstet Gynaecol; 1984 Oct; 91(10):1031-6. PubMed ID: 6541503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogenic potency of oral replacement therapy estimated by the induction of pregnancy zone protein.
    Helgason S; Damber MG; von Schoultz B; Stigbrand T
    Acta Obstet Gynecol Scand; 1982; 61(1):75-9. PubMed ID: 6283781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma concentrations of unconjugated and conjugated estrogens and gonadotrophins following application of various estrogen preparations after oophorectomy and in the menopause.
    Strecker JR; Lauritzen C; Goessens L
    Maturitas; 1979 Feb; 1(3):183-90. PubMed ID: 228157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of the estrogenic effects of tamoxifen and 17 beta-estradiol in postmenopausal women.
    Helgason S; Wilking N; Carlström K; Damber MG; von Schoultz B
    J Clin Endocrinol Metab; 1982 Feb; 54(2):404-8. PubMed ID: 6798066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term effects of smoking on the pharmacokinetic profiles of micronized estradiol in postmenopausal women.
    Cassidenti DL; Vijod AG; Vijod MA; Stanczyk FZ; Lobo RA
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1953-60. PubMed ID: 2256508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure.
    Hassager C; Riis BJ; Strøm V; Guyene TT; Christiansen C
    Circulation; 1987 Oct; 76(4):753-8. PubMed ID: 3308164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of percutaneous estradiol and conjugated estrogens on the level of plasma proteins and triglycerides in postmenopausal women.
    Elkik F; Gompel A; Mercier-Bodard C; Kuttenn F; Guyenne PN; Corvol P; Mauvais-Jarvis P
    Am J Obstet Gynecol; 1982 Aug; 143(8):888-92. PubMed ID: 6285744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.